Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
FBIOP US34960Q2084
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Rosenwald Lindsay A Md PR |
1.84 USD |
763,359 Bought |
1,404,581 USD |
23/09/2024 | 23/09/2024 |
| Rosenwald Lindsay A Md CEO |
7.48 USD |
5,000 Bought |
37,418 USD |
11/07/2024 | 11/07/2024 |
| Jin David CFO |
7.50 USD |
500 Bought |
3,750 USD |
10/07/2024 | 10/07/2024 |
| Rosenwald Lindsay A Md CEO |
7.39 USD |
5,000 Bought |
36,971 USD |
09/07/2024 | 09/07/2024 |
| Rosenwald Lindsay A Md CEO |
7.35 USD |
5,000 Bought |
36,765 USD |
08/07/2024 | 08/07/2024 |
| Rosenwald Lindsay A Md CEO |
1.64 USD |
20,000 Bought |
32,724 USD |
28/06/2024 | 28/06/2024 |
| Klein Dov O |
1.89 USD |
10,000 Sold |
18,900 USD |
20/05/2024 | 20/05/2024 |
| Rosenwald Lindsay A Md CEO |
1.76 USD |
10,000 Bought |
17,589 USD |
16/05/2024 | 16/05/2024 |
| Rosenwald Lindsay A Md CEO |
2.38 USD |
50,000 Bought |
118,770 USD |
05/01/2024 | 05/01/2024 |
| Weiss Michael S O |
1.70 USD |
147,058 Bought |
249,999 USD |
14/11/2023 | 14/11/2023 |